What to do about pre-clinical RA?
Mar 20, 2023
Latest ACR News
Read ArticleMuch like the recent ACR Convergence, RheumNow Live’s 2023 conference started and focused on this year’s hot topic of rheumatoid arthritis and especially what to do regarding pre-clinical RA.
Making Better Posters: Dr. David Liew
Dr. David Liew describes how some presenters are working to make their posters better design-wise to improve their presentation at the 2019 ACR/ARP annual meeting in Atlanta.
Romosozumab and Patients with Chronic Kidney Disease: Dr. Arthur Lau
Dr. Lau discusses abstract #2730 presented at the 2019 ACR/ARP annual meeting in Atlanta.
SJIA-associated ILD: Dr. Jonathan Hausmann
Dr. Hausmann describes a new inflammatory lung disease at the 2019 ACR/ARP annual meeting in Atlanta.
Lupus Pearls: Dr. Kathryn Dao
Dr. Dao reviews several lupus pearls presented by Dr. Michelle Petri at the 2019 ACR/ARP Annual Meeting in Atlanta.
Panel Presentation: Gout
Drs. Jack Cush, Nicola Dalbeth, Ken Saag, and Robert Keenan discuss key presentations related to gout presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Myosin Regulation May Contribute to Anti-TNF Therapy Response: Dr. Elaine Husni
Dr. Husni highlights abstract #1769 as presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Inflammatory Arthritis Persists After Immunotherapy Cessation: Dr. David Liew
Dr. Liew discusses abstract #1808 Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis Persists After Immunotherapy Cessation presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Studies on the Changing Face of RA: Dr. Janet Pope
Dr. Pope discusses abstract #171, #172 and #841 as presented at the 2019 ACR/ARP Annual Meeting in Atlanta.
Panel Presentation: Rheumatoid Arthritis
Drs. Jack Cush, Arthur Kavanaugh and Jonathan Kay discuss several rheumatoid arthritis studies presented at the 2019 ACR/ARP Annual Meeting in Atlanta. Abstracts discussed include abstract #1342, #1350, #1160, and more.
Drug Levels Associated with Lupus Flares: Dr. Janet Pope:
Dr. Pope discusses abstract #2567 Prospective Evaluation of American Academy of Ophthalmology Low Dose Hydroxychloroquine Recommendation in Stable Lupus Nephritis with High-Risk Retinopathy: Lipid Profile and Flare Rates presented at the 2019 ACR/ARP annual meeting in Atlanta.
Safety of Methotrexate (The CIRT Trial): Dr. Jack Cush
Dr. Cush discusses abstract #1890 on the CIRT trial as presented at the 2019 ACR/ARP annual meeting in Atlanta.
Dr. Dao talks with Dr. Gwenesta Melton about Women in Rheumatology
Dr. Dao interviews Dr. Melton about Women in Rheumatology
Social Media Professionalism: Dr. Michael Putman and Dr. Jilaine Bolek Berquist
Dr. Michael Putman talks with Dr. Jilaine Bolek Berquist about her talk on tweets and trolls in social media at the 2019 ACR/ARP annual meeting in Atlanta.
Domain Strategy and Treatment in Psoriatic Arthritis: Dr. Elaine Husni
Dr. Elaine Husni reviews her talk on domain strategies in PsA at the 2019 ACR/ARP annual meeting in Atlanta.
